ATC code R07

Pharmaceutical drug classification

ATC code R: Respiratory system

* R01 Nasal preparations
* R02 Throat preparations
* R03 Drugs for obstructive airway diseases
* R05 Cough and cold preparations
* R06 Antihistamines for systemic use
* R07 Other respiratory system products

Other ATC codes

* A
* B
* C
* D
* G
* H
* QI
* J
* L
* M
* N
* P
* R
* S
* V

ATC code R07 Other respiratory system products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup R07 is part of the anatomical group R Respiratory system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR07.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

## R07A Other respiratory system products

[edit]

### R07AA Lung surfactants

[edit]

R07AA01 Colfosceril palmitate
R07AA02 Natural phospholipids
R07AA30 Combinations

### R07AB Respiratory stimulants

[edit]

R07AB01 Doxapram
R07AB02 Nikethamide
R07AB03 Pentetrazol
R07AB04 Etamivan
R07AB05 Bemegride
R07AB06 Prethcamide
R07AB07 Almitrine
R07AB08 Dimefline
R07AB09 Mepixanox
R07AB52 Nikethamide, combinations
R07AB53 Pentetrazol, combinations
QR07AB99 Respiratory stimulants, combinations

### R07AX Other respiratory system products

[edit]

R07AX01 Nitric oxide
R07AX02 Ivacaftor
R07AX30 Ivacaftor and lumacaftor
R07AX31 Ivacaftor and tezacaftor
R07AX32 Ivacaftor, tezacaftor and elexacaftor
R07AX33 Deutivacaftor, tezacaftor and vanzacaftor

## References

[edit]

1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. ^ "ATC/DDD Index 2022: code R07". WHO Collaborating Centre for Drug Statistics Methodology.
5. ^ "ATCvet Index 2022: code QR07". WHO Collaborating Centre for Drug Statistics Methodology.

* v
* t
* e

Other respiratory system products (R07)

Lung surfactants|

* Colfosceril palmitate
* Dipalmitoylphosphatidylcholine

Respiratory stimulants|

* Almitrine
* Amiphenazole
* Bemegride
* Dimefline
* Doxapram
* Etamivan
* GAL-021
* Mepixanox
* Nikethamide
* Pentetrazol
* Prethcamide

5-HT4 receptor agonists|

* BIMU-8
* Zacopride

Other agents for treating respiratory depression|

* Ivacaftor (+ lumacaftor, + tezacaftor, + elexacaftor/tezacaftor)
* Nitric oxide
* Vanzacaftor/tezacaftor/deutivacaftor
* BW373U86
* CX-546
* CX-717

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template